Developing autologous stem cell therapies for debilitating neurodegenerative diseases - Lebovits, CEO, Brainstorm Cell Therapeutics Inc 00:00:00
Chaim Lebovits joined BrainStorm in July 2007 as President and has served as Chief Executive Officer since September 2015. He has been instrumental in shaping development of the NurOwn® technology platform from early preclinical stages to the current phase 3 clinical program in the United States.